RAG2 and neoplasm: Progressive tumor growth was only noted when the lymphoma cells were injected into the Rag2-/- recipients (100% tumor incidence), significantly lower tumor incidence occurred when the cells were transplanted into wild-type mice (7%, p < 0.0001 vs. Rag2-/- control, Fisher exact test).